Stay updated on CAB-AXL-ADC in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.

Latest updates to the CAB-AXL-ADC in Sarcoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA consolidated Locations section listing all participating sites by state/country was added and the page revision updated to v3.3.3; individual state location entries and the HHS Vulnerability Disclosure link were removed.SummaryDifference2%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; no changes to study details or content are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check51 days agoChange DetectedDifference0.3%

- Check65 days agoChange DetectedThe study record now shows updated dates (Primary Completion Actual 2025-01-08; Study Completion Actual 2025-01-08) and the latest Last Update Posted date, with enrollment listed as 245 across sites.SummaryDifference0.3%

- Check94 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%

Stay in the know with updates to CAB-AXL-ADC in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.